This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of compounds targeting central nervous system disorders, such as depression, anxiety, and neurodegenerative diseases. Its structure allows for modifications that can enhance binding affinity to specific receptors, making it valuable in the design of selective serotonin reuptake inhibitors (SSRIs) and other neuroactive agents. Additionally, it is explored in the development of small molecule therapies for pain management and cognitive enhancement. Its hydrochloride form ensures stability and solubility, facilitating its use in various experimental and preclinical studies.